Epilepsy Pipeline Tracker

 
The mission of the Epilepsy Foundation includes accelerating new therapies for people living with epilepsy and seizures. As a reflection of our commitment and as a service to the community we are pleased to provide here the pipeline of epilepsy therapies in various stages of development. We thank all of the individuals and organizations whose efforts are reflected in these seeds of hope. The Epilepsy Foundation makes no claims of accuracy of the following data. Although every effort is made to continuously update this list, some errors are inevitable. Companies or academicians or others who are directly involved with any of the therapies listed here are strongly encouraged to keep us updated by contacting contactus@efa.org of any needed changes.
NEW DRUGS IN DEVELOPMENT edit

2-deoxy-D-glucose (2DG) for the Treatment of Epilepsy

  • PRE
  • P1
  • P2
  • P3
Sponsors / Collaborators NeuroGenomeX, Inc., in collaboration with University of Wisconsin and University of Virginia, EF, MFF
Mechanism of Action |Other : Inhibits Glycolysis
View Details
NEW THERAPEUTIC DEVICES edit

3D Machine Vision System for Surgical Navigation of the Human Brain

Phase of Development Prototype Development
Sponsors / Collaborators Advanced Scanners, Epilepsy Foundation (EF)
Mechanism of Action |Surgical Procedure : 3D imaging during surgury
ex-US Approval: N/A
View Details
NEW DIAGNOSTIC TOOLS edit

a-methyl-Tryptophan-conjugated Magnetonanoparticles for Enhanced Therapy of Epilepsy

Phase of Development Prototype Development
Sponsors / Collaborators UCLA School of Medicine, Epinano, Epilepsy Foundation (EF)
Mechanism of Action |Imaging : N/A
Software/Hardware/Both Both
View Details
NEW DRUGS IN DEVELOPMENT edit

ACT-709478

  • PRE
  • P1
  • P2
  • P3
Sponsors / Collaborators Actelion (J&J company) / Idorsia Pharmaceuticals Ltd.
Mechanism of Action |Ion Channel : Selective T-type Calcium Channel Blocker
View Details

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline